GET THE APP

The Impact of COVID-19 on suicidal cases

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Review Article - (2022) Volume 10, Issue 12

The Impact of COVID-19 on suicidal cases

Sarvesh Ravi Kandoi, Pramita Gharde* and Ashok Mehendale

*Correspondence: Dr. Pramita Gharde, Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institiute of Medical Sciences (Deemed to be University), Maharashtra, India, Email:

Author info »

Abstract

Multiple lines of evidence indicate that the Coronavirus disease-2019 (COVID-19) pandemic has profound psychological and social effects. The psychological squeal of the pandemic will probably persist for months and years to come. Studies indicate that the COVID-19 pandemic is associated with distress, anxiety, fear of contagion, depression and insomnia in the general population and among healthcare professionals. Social isolation, anxiety, fear of contagion, uncertainty, chronic stress and economic difficulties may lead to the development or exacerbation of depressive, anxiety, substance use and other psychiatric disorders in vulnerable populations including individuals with pre-existing psychiatric disorders and people who reside in high COVID-19 prevalence areas. Stress related psychiatric conditions including mood and substance use disorders are associated with suicidal behavior. COVID-19 survivors may also be at elevated suicide risk. The COVID-19 crisis may increase suicide rates during and after the pandemic. Mental health consequences of the COVID-19 crisis including suicidal behavior are likely to be present for a long time and peak later than the actual pandemic. To reduce suicides during the COVID-19 crisis, it is imperative to decrease stress, anxiety, fears and loneliness in the general population. There should be traditional and social media campaigns to promote mental health and reduce distress. Active outreach is necessary, especially for people with a history of psychiatric disorders, COVID-19 survivors and older adults. Research studies are needed of how mental health consequences can be mitigated during and after the COVID-19 pandemic.

Keywords

Psychological squeal, Anxiety, Psychiatric disorders, Depression, Social isolation

Introduction

The Coronavirus disease 2019 (COVID-19) pandemic began at the end of 2019 in China and has quickly spread globally. Millions of people around the world are infected and hundreds of thousands have died. The clinical manifestations of COVID-19 vary from asymptomatic forms to severe clinical conditions characterized by respiratory failure, sepsis, septic shock and multiple organ dysfunction syndromes [1]. Understandably, medical professionals and public health specialists are focused on taking care of individuals who are very sick, while containing the Coronavirus’s spread in the general population. Less attention is given to the psychiatric consequences of the COVID-19 crisis.

Multiple lines of evidence indicate that the COVID-19 pandemic has profound psychological and social effects [2]. There is a pervasive awareness of uncertainty over the future and an understanding that the pandemic is far from over. It is possible that there will be economic privation and political upheaval. The psychological squeal of the pandemic will probably persist for months and years to come. In this article, I suggest that the COVID-19 pandemic may increase the prevalence of psychiatric disorders and suicide rates during and after the pandemic.

Nothing in our lifetimes can be compared with the magnitude of the COVID-19 disaster. The last comparable crisis was the pandemic of Spanish flu in 1918-19 caused by H1N1 viruses with genes of avian origin. About 500 million people or one third of the world’s population were infected with the Spanish flu viruses and at least 50 million people perished around the world including about 675,000 in the USA [3]. The Spanish flu epidemic was associated with an increase in death by suicide. It has been proposed that a decrease in social integration and interaction during the epidemic and the fears caused by the epidemic likely increased suicide [4]. It is important to note that social isolation and fears are common during the current COVID-19 epidemic.

There was a significant increase in suicide deaths among people aged 65 and over during the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak in Hong Kong [5]. Research indicates that this increase in suicides can be attributed to fears of contracting the illness, fears of being a burden to the family, general anxiety, social isolation and psychological distress.

A number of studies have been performed to examine the effect of the COVID-19 crisis on the mental health of the general population, health care professionals and individuals with psychiatric disorders. Wang, et al. examined psychological responses during the initial stage of the COVID-19 epidemic in the general population in China. The authors found that 53.8% of 1210 respondents rated the psychological impact of the outbreak as moderate or severe, 16.5% reported moderate to severe depressive symptoms and 28.8% reported moderate to severe anxiety symptoms. Qiu, et al. performed a countrywide survey that included 52,730 people in China during the COVID-19 epidemic and found that about 35% of the participants had psychological distress [7]. This is consistent with the results of a recent Kaiser family foundation survey indicating that 45% of adults in the USA report that their mental health has been negatively impacted due to worry and stress over the Coronavirus [8].

Li, et al. analyzed online posts made by 17,865 Chinese social media customers before and after the declaration of COVID-19 in China on 20 January 2020 [9]. The authors observed that negative emotions including anxiety, depression and anger rose, whereas the positive emotions and life satisfaction diminished. Xiao, et al. studied a relationship between social capital as measured by the personal social capital scale and sleep characteristics in person who were isolated during the COVID-19 epidemic [10]. Researchers observed that anxiety was associated with stress and reduced sleep quality and the combination of anxiety and stress reduced the positive effects of social capital on sleep quality. Xiao, et al. wrote that ‘anxiety and stress of isolated individuals were at high levels, whereas the sleep quality was low’ [10].

Ahmed, et al. did an online survey of 1074 Chinese people and found elevated rates of anxiety, depression, harmful alcohol use and decrease in mental wellbeing [11]. Rates of anxiety and depression were higher among young people aged 21-40 years in comparison to other age groups. Huang and Zhao conducted a web based survey of 7236 individuals in China [12]. The overall prevalence of generalized anxiety disorder, depressive symptoms and sleep abnormalities were 35.1%, 20.1% and 18.2% respectively. This study also showed that health care professionals were more likely to have poor sleep quality in comparison to other occupational groups.

Lai, et al. examined a state of mental health of 1257 health care professionals in China. 50.4% of study participants reported depression, 44.6% anxiety, 34.0% insomnia and 71.5% distress [13]. Frontline health care professionals who were taking care of patients with COVID-19 had a higher risk of having symptoms of depression, anxiety, insomnia and distress in comparison to other medical professionals. In March 2020, Ahmed, et al. did an online study to examine anxiety and fear of getting infected among dentists [14]. The authors received responses from 669 dentists from 30 countries. An overwhelming majority of study participants reported anxiety and fear of contagion. Some dentists closed their practices for an indefinite period of time.

Hao, et al. compared the psychological impact of the COVID-19 epidemic on individuals with or without mood and anxiety disorders [15]. Worries about their physical health, anger, impulsivity and suicidal ideation were significantly higher in psychiatric patients than in healthy controls.

Probably, alcohol consumption increases during the COVID-19 crisis. According to a market research firm Nielsen, US sales of alcoholic beverages rose 55% in the week ending 21 March 2020 compared with the same period last year [16]. Online alcohol sales jumped 243%.

Multiple cases of COVID-19 related suicides in the USA, UK, Italy, Germany, Bangladesh, India and other countries have been reported in mass media and psychiatric literature. For example, a 19 years old waitress in England died in a hospital after a suicide attempt because of fears of the ‘mental health impacts’ of isolation [17]. A 66 years old man with throat cancer hanged himself in a New York City hospital after testing positive for the Coronavirus [18]. A man in Illinois who feared that he and his girlfriend contracted the Coronavirus fatally shot his girlfriend and then killed himself [19]. They tested negative for the Coronavirus. A 36 years old Bangladeshi man killed himself because he and people in his village thought that he was infected with COVID-19 because he had fever and cold symptoms [20]. A postmortem examination showed that he did not have COVID-19. The 49 years old head of the emergency department in a New York city hospital died by suicide after telling her family about the tremendous suffering and death she witnessed while taking care of Coronavirus patients [21]. Also, there is a huge increase of calls to suicide prevention hotlines in the USA during the current COVID-19 epidemic [22].

In summary, studies indicate that the COVID-19 pandemic is associated with distress, anxiety, fear of contagion, depression and insomnia in the general population. Health care professionals are especially distressed.

Discussion

Suicidal behavior in the COVID-19 era

Social isolation, anxiety, fear of contagion, uncertainty, chronic stress and economic difficulties may lead to the development or exacerbation of stress related disorders and suicidality in vulnerable populations including individuals with pre-existing psychiatric disorders, low resilient persons, individuals who reside in high COVID-19 prevalence areas and people who have a family member or a friend who has died of COVID-19 [23,24]. Individuals with pre-existing psychiatric disorders include not only patients who are treated by mental health professionals but also a very large number of people with psychiatric conditions who do not receive psychiatric treatment [25,26]. For example, an international study that included the data from countries in Europe, North and South America, Asia and Australia showed that the median untreated rates for schizophrenia, major depression and alcohol use disorder were 32.2%, 56.3% and 78.1%, respectively. Community epidemiological research in the USA shows that a majority of individuals with mood disorders are either untreated or undertreated.

Social isolation contributes to the pathophysiology of psychiatric disorders and suicidal behavior. In his famous book on suicide, Durkheim emphasized that social connectedness is a critical factor in emotional health and social stability [27]. The Irish longitudinal study on ageing as well as other research investigations demonstrated that social isolation and loneliness are associated with major depression and generalized anxiety disorder [28,29]. Studies have shown that both objective social isolation (e.g. living alone) and subjective sense of being alone are associated with suicidal ideation and behavior. These observations are consistent across diverse cultures and populations. For example, the Quebec health survey showed that living alone and having no friends were associated with both suicidal ideation and suicide attempts [30]. Social disengagement played a role in the increased suicide rate during the 2003 SARS epidemic in Hong Kong. One third of SARS related suicide victims experienced social isolation during the SARS outbreak. From a suicide prevention perspective, it is troubling that the most important public health approach for the COVID-19 epidemic is social distancing.

Anxiety and fear of contagion during the COVID-19 crisis may be related to uncertainty, fear of unknown and panic inducing stories in traditional and social media. Repeated exposure to reports about the COVID-19 crisis can intensify anxiety. Worries and fears cause various mental and physical symptoms and may lead to the development of anxiety disorders, depression and sleep disorders. Studies suggest that the relationships between insomnia and depression and insomnia and anxiety are bidirectional [31]. Sleeplessness contributes to symptoms of depression and anxiety and contrariwise, symptoms of depression and anxiety disturb sleep. Sleep disturbances are a standalone risk factor for suicidal behavior [32].

Uncertainty, especially economic uncertainty is associated with stress related disorders and suicide [33,34]. It has been shown that uncertainty is a more stressful state to be in than really knowing something bad will happen [35]. Uncertainty is associated with depression and anxiety. In one research investigation, daily suicide data from England and Wales were matched to a daily economic policy uncertainty index over the period 2001-15. The authors found that a spike in daily economic uncertainty lead to an immediate impact on suicides which suggest that economic uncertainty may lead to an increase in the risk of suicide.

The impact of economic problems related to the COVID-19 crisis on mental health may be severe. Millions of people around the world lost their jobs. Measures required containing the virus, including self-isolation by workers and consumers, shutting of plants and stores and prohibitions on sports and entertainment events are detrimental for economy. Historically, economic downturns were associated with mental health disorders and suicides. Studies observed that increases in the unemployment rate were associated with higher prevalence of depression, alcohol and other substance use disorders and suicide deaths [36]. Both perceived job insecurity and unemployment constitute significant risks of increased depressive symptoms in prospective observational studies [37]. In the USA, suicides increased during the great depression. Suicide mortality peaked with unemployment, in the most recessionary years, 1921, 1932 and 1938 [38]. Suicide rates also increased in other countries during the great depression. For example, Varnik reported a rise in suicide death in Estonia in the early 1930’s [39]. Reeves, et al. observed that almost all European countries have experienced rising suicide rates during the 2008-10 recessions [40]. The authors estimated that, in total, there were at least 10,000 more economic suicides during the recession in the European Union, Canada and the USA than would have been expected. Economic decline during and after the COVID-19 pandemic will probably have a powerful and harmful effect on mental health and result in an increase in the prevalence of psychiatric disorders and suicidal behavior. It is important to note that financial problems may reduce access to psychiatric treatment.

There is a high probability that the COVID-19 survivors especially survivors who had severe COVID-19 are at elevated suicide risk [41]. Stressful experiences such as learning about the diagnosis of COVID-19, fear of infecting others, symptoms of the illness, hospitalization, especially admission to an intensive care unit and loss of income may lead to the development of anxiety, depressive and post-traumatic stress disorder [41,42]. A recent study in China indicated that 96.2% of recovering COVID-19 patients had significant posttraumatic stress symptoms [43]. Around 50% of recovered patients remained anxious after the 2003 SARS epidemic in Hong Kong [44]. COVID-19 infection is associated with neurological conditions including acute ischemic stroke, headache, dizziness, ataxia and seizures. A recent review of the impact of the COVID-19 on the brain show that neurological conditions are present in about 25% of the COVID-19 patients [45]. Many recovering COVID-19 patients have physical symptoms including pain for a long time [46]. Neurological disorders such as ischemic stroke, headache and seizures are associated with suicidal behavior [47]. Physical symptoms, especially pain also increase suicide risk [48].

Psychiatric conditions including mood, anxiety, sleep and substance use disorders are associated with suicidal behavior. Studies in the USA suggest that >90% of suicide victims have a psychiatric disorder. For example, depression is a major risk factor for suicide, accounting for up to 60% of suicide deaths [49]. Mental health consequences of the COVID-19 crisis including suicidal behavior are likely to be present for a long time and peak later than the actual pandemic.

There is a high probability that suicide rates will increase in many countries of the world. This problem may be especially difficult in the US. Suicide rates have been steadily growing in the USA over the last two decades [50]. From 1999 through 2017, the age adjusted suicide rate in the USA grew 33% from 10.5 to 14.0 per 100,000 [50]. For women, the rate grew 53% from 4.0 in 1999 to 6.1 in 2017. For men, the rate grew 26% from 17.8 in 1999 to 22.4 in 2017. If suicide rates increase in the USA, it will add to the trend of rising national rates of suicide. An increase in suicide rates may become a significant public health issue in other countries.

Suicide prevention in the COVID-19 era

In 1994, the institute of medicine (now the national academy of medicine) committee on prevention of mental disorders suggested that prevention of psychiatric conditions should be divided into three categories: Universal preventive interventions, selective preventive interventions and indicated preventive interventions [51]. Suicide prevention efforts during the COVID-19 crisis can also classified as universal, selective or indicated.

A universal approach is designed for everyone in the general population regardless of their risk for suicide. To reduce suicides during the COVID-19 crisis it is imperative to decrease stress, anxiety, fears and loneliness in the general population. There should be traditional and social media campaigns to promote mental health and reduce distress. People need to be encouraged to stay connected and maintain relationships by telephone or video get enough sleep, eat healthy food and exercise. It is vital to deliver community support for those living alone and to encourage families and friends to check in. Screenings for anxiety, depression and suicidal feelings ought to be employed. Transparent, timely and responsible media reporting is absolutely necessary. Community or organizational gate keepers including clergy, first responders, pharmacists, geriatric caregivers and school employees may have an opportunity to identify individuals at risk for suicide and direct them to proper evaluation and treatment. Suicide prevention helplines should be available and may be very useful in preventing suicides. Integration of basic mental health services into outpatient primary care may help to minimize the harmful psychological effects of the COVID-19 crisis. Whenever possible, governments and non-governmental organizations should provide financial support for people in needs. This may include direct cash payments, postponement of loan repayments, tax credits etc.

A selective approach is for sub groups at increased risk for suicide, for example, for individuals with a history of psychiatric disorders, persons with symptoms of significant emotional distress, COVID-19 survivors, frontline health care professionals and elderly people [52]. Active outreach is necessary, especially for people with a history of psychiatric disorders, COVID-19 survivors and older adults. People with psychiatric disorders should be advised to continue their treatment regimens and to stay in touch with their mental health professionals. Some psychiatric patients may need adjustments in their treatment and increased frequency of contact with their mental health clinicians. Telemedicine can improve accessibility of mental health care. Also, vulnerable individuals should be advised to limit watching, reading or listening to traditional and social media news stories.

An indicated approach is designed for individuals who have a risk factor or condition that puts them at very high risk for suicide, e.g. a recent suicide attempt. Individuals in suicidal crises need special attention. Some suicidal persons might not seek help because of fear that attending face to face appointments with a health care professional might put them at risk of contracting COVID-19 or because of other reasons. Therefore, individuals with a recent suicide attempt history need a follow up. Clinicians should have well defined guidelines on how to deal with suicidal individuals.

Conclusion

Suicide prevention in the COVID-19 era is an important and difficult issue. Research studies are needed of how mental health consequences can be mitigated during and after the COVID-19 pandemic. It is to be hoped that the efforts of clinicians, researchers and policy makers will reduce COVID-19 related suicides.

References

    1. Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment Coronavirus (COVID-19). StatPearls 2020.

      [Googlescholar][Indexed]

    2. Ornell F, Schuch JB, Sordi AO, et al. “Pandemic fear” and COVID-19: Mental health burden and strategies. Braz J Psychiatry 2020; 42:232–235.

      [Crossref][Googlescholar][Indexed]

    3. Centers for Disease Control and Prevention (CDCP). 1918 Pandemic (H1N1 virus). 2020.
    4. Wasserman IM. The impact of epidemic, war, prohibition and media on suicide: United States, 1910-1920. Suicide Life Threat Behav 1992; 22:240–254.

      [Googlescholar][Indexed]

    5. Yip PS, Cheung YT, Chau PH, et al. The impact of epidemic outbreak: The case of Severe Acute Respiratory Syndrome (SARS) and suicide among older adults in Hong Kong. Crisis 2010; 31:86–92.

      [Crossref][Googlescholar][Indexed]

    6. Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 Coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020; 17:1729.

      [Crossref][Googlescholar][Indexed]

    7. Qiu J, Shen B, Zhao M, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: Implications and policy recommendations. Gen Psychiatr 2020; 33:e100213.

      [Crossref][Googlescholar][Indexed]

    8. Panchal N, Kamal R, Orgera K, et al. The implications of COVID-19 for mental health and substance use. Kaiser Family Foundation 2020; 21:1-16.

      [Googlescholar]

    9. Li S, Wang Y, Xue J, et al. The impact of COVID-19 epidemic declaration on psychological consequences: A study on active weibo users. Int J Environ Res Public Health 2020; 17:2032.

      [Crossref][Googlescholar][Indexed]

    10. Xiao H, Zhang Y, Kong D, et al. Social capital and sleep quality in individuals who self-isolated for 14 days during the Coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China. Med Sci Monit 2020; 26:e923921.

      [Crossref][Googlescholar][Indexed]

    11. Ahmed MZ, Ahmed O, Aibao Z, et al. Epidemic of COVID-19 in China and associated psychological problems. Asian J Psychiatr 2020; 51:102092.

      [Crossref][Googlescholar][Indexed]

    12. Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: A web based cross sectional survey. Psychiatry Res 2020; 288:112954.

      [Crossref][Googlescholar][Indexed]

    13. Lai J, Ma S, Wang Y, et al. Factors associated with mental health outcomes among health care workers exposed to Coronavirus Disease 2019. JAMA Netw Open 2020; 3:e203976.

      [Crossref][Googlescholar][Indexed]

    14. Ahmed MA, Jouhar R, Ahmed N, et al. Fear and practice modifications among dentists to combat novel Coronavirus Disease (COVID-19) outbreak. Int J Environ Res Public Health 2020; 17:2821.

      [Crossref][Googlescholar][Indexed]

    15. Hao F, Tan W, Jiang L, et al. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case control study with service and research implications for immunopsychiatry. Brain Behav Immun 2020; 87:100-106.

      [Crossref][Googlescholar][Indexed]

    16. Associated Press (AP). Booze buying surges; senators push airlines for cash refunds. 2020.

      [Indexed]

    17. Miller JR. British teen dies after suicide attempt due to Coronavirus fears. New York. 2020.
    18. Moore T, Bensimon O. Man with cancer commits suicide at NYC hospital after getting Coronavirus. New York. 2020.
    19. Garger K. Illinois couple dead in murder suicide after man feared they had Coronavirus. New York. 2020.
    20. Mamun MA, Griffiths MD. First COVID-19 suicide case in Bangladesh due to fear of COVID-19 and xenophobia: Possible suicide prevention strategies. Asian J Psychiatr 2020; 51:102073.

      [Crossref][Googlescholar][Indexed]

    21. Rosner E, Sheehy K. Top Manhattan ER doc commits suicide, shaken by Coronavirus onslaught. New York Post 2020.
    22. Dunmore R. Coronavirus related suicides surface amid increased anxiety. Newsone 2020.

      [Googlescholar]

    23. Lieberman JA, Olfson M. Meeting the mental health challenge of the COVID-19 pandemic. Psychiatric Times 2020.

      [Googlescholar]

    24. Sher L. Resilience as a focus of suicide research and prevention. Acta Psychiatr Scand 2019; 140:169–180.

      [Crossref][Googlescholar][Indexed]

    25. Kohn R, Saxena S, Levav I, et al. The treatment gap in mental health care. Bull World Health Organ 2004; 82:858–866.

      [Googlescholar][Indexed]

    26. Kessler RC, Merikangas KR, Wang PS. Prevalence, comorbidity and service utilization for mood disorders in the United States at the beginning of the twenty first century. Annu Rev Clin Psychol 2007; 3:137–158.

      [Crossref][Googlescholar][Indexed]

    27. Durkheim E. A study in sociology. 2nd Edition. Snowball Publ 2002; 297–325.

      [Crossref][Googlescholar]

    28. Domenech Abella J, Mundo J, Haro JM, et al. Anxiety, depression, loneliness and social network in the elderly: Longitudinal associations from the irish longitudinal study on ageing (TILDA). J Affect Disord 2019; 246:82–88.

      [Crossref][Googlescholar][Indexed]

    29. Calati R, Ferrari C, Brittner M, et al. Suicidal thoughts and behaviors and social isolation: A narrative review of the literature. J Affect Disord 2019; 245:653–667.

      [Crossref][Googlescholar][Indexed]

    30. Stravynski A, Boyer R. Loneliness in relation to suicide ideation and parasuicide: A population wide study. Suicide Life Threat Behav 2001; 31:32–40.

      [Crossref][Googlescholar][Indexed]

    31. Acharya S, Shukla S, Acharya N. Gospels of a pandemic-A metaphysical commentary on the current COVID-19 crisis. J Clin Diagn Res 2020; 14:OA01–OA02.

      [Crossref][Googlescholar]

    32. Arora D, Sharma M, Acharya S, et al. India in “flattening the curve” of COVID-19 pandemic Triumphs and challenges thereof. J Evol Med Dent Sci 2020; 9:3252–3255.

      [Googlescholar]

    33. Bawiskar N, Andhale A, Hulkoti V, et al. Haematological manifestations of COVID-19 and emerging immuno haematological therapeutic strategies. J Evol Med Dent Sci 2020; 9:3489–3494.

      [Googlescholar]

    34. Burhani TS, Naqvi WM. Tele health a boon in the time of COVID-19 outbreak. J Evol Med Dent Sci 2020; 9:2081–2084.

      [Googlescholar]

    35. Butola LK, Ambad R, Kute PK, et al. The pandemic of 21st century COVID-19. J Evol Med Dent Sci 2020; 9:2913–2918.

      [Googlescholar][Indexed]

    36. Dhok A, Butola LK. Anjankar A, et al. Role of vitamins and minerals in improving immunity during COVID-19 pandemic-A review. J Evol Med Dent Sci 2020; 9:2296–2300.

      [Googlescholar]

    37. Gawai JP, Singh S, Taksande VD, et al. Critical review on impact of COVID-19 and mental health. J Evol Med Dent Sci 2020; 9:2158–2163.

      [Googlescholar][Indexed]

    38. Khubchandani SR, Dahane TM. Emerging therapeutic options for COVID-19. J Evol Med Dent Sci 2020; 9:3082–3085.

      [Googlescholar][Indexed]

    39. Kolhe S, Dambhare M, Dhankasar P, et al. Home remedies during COVID pandemic lockdown. J Evol Med Dent Sci 2020; 8:103–107.

      [Googlescholar][Indexed]

    40. Pate BS, Yeola ME, Gawande A, et al. Best practices for endoscopic procedures in COVID-19 pandemic. J Evol Med Dent Sci 2020; 9:3760–3766.

      [Googlescholar][Indexed]

    41. Patel A, Patel S, Fulzele P, et al. Quarantine an effective mode for control of the spread of COVID19? A review. J Family Med Prim Care 2020; 9:3867–3871.

      [Crossref][Googlescholar][Indexed]

    42. Sigh N, Anjankar AP, Garima S. The urgent need to understand COVID-19 associated coagulopathies and the significance of thrombotic prophylaxis in critically ill patients. J Evol Med Dent Sci 2020; 9:2381–2385.

      [Googlescholar][Indexed]

    43. Soorthy MS, Pratapa SK, Mahant S. Mental health problems faced by healthcare workers due to the COVID-19 pandemic-A review. Asian J Psychiatr 2020; 51.

      [Crossref][Googlescholar][Indexed]

    44. Jakhar D, Sharma A, Kaur I, et al. Indian dermatologists wield technology to combat COVID-19. Indian Dermatol Online J 2020; 11:991–994.

      [Crossref][Googlescholar][Indexed]

    45. Kute V, Guleria S, Prakash J, et al. NOTTO transplant specific guidelines with reference to COVID-19. Indian J Nephrol 2020; 30:215–220.

      [Crossref][Googlescholar][Indexed]

    46. D’Ambrosio A. COVID-19 sequelae can linger for weeks. MedPage 2020.

      [Googlescholar]

    47. Hudzik TJ, Marek GJ. Neurological disease and suicidal behavior. In: Cannon KE, Hudzik TJ, (eds). Suicide: Phenomenology and neurobiology. Springer 2014; 155-166.

      [Crossref][Googlescholar]

    48. Ahmedani BK, Peterson EL, Hu Y, et al. Major physical health conditions and risk of suicide. Am J Prev Med 2017; 53:308–315.

      [Crossref][Googlescholar][Indexed]

    49. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: A systematic review. JAMA 2005; 294:2064–2074.

      [Crossref][Googlescholar][Indexed]

    50. Hedegaard H, Curtin SC, Warner M. Suicide mortality in the United States, 1999-2017. NCHS Data Brief 2020; 362:1–8.

      [Googlescholar][Indexed]

    51. Munoz RF, Mrazek PJ, Haggerty RJ. Institute of medicine report on prevention of mental disorders. Summary and commentary. Am Psychologist 1996; 51:1116–1122.

      [Crossref][Googlescholar][Indexed]

    52. Sher L. Preventing suicide. QJM 2004; 97:677–680.

      [Crossref][Googlescholar][Indexed]

Author Info

Sarvesh Ravi Kandoi, Pramita Gharde* and Ashok Mehendale

Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institiute of Medical Sciences (Deemed to be University), Maharashtra, India
 

Citation: Sarvesh Ravi Kandoi, Pramita Gharde, Ashok Mehendale, The Impact of COVID-19 on Suicidal Cases, J Res Med Dent Sci, 2022, 10 (12): 220-225.

Received: 10-Oct-2022, Manuscript No. JRMDS-22-64818; , Pre QC No. JRMDS-22-64818(PQ); Editor assigned: 14-Oct-2022, Pre QC No. JRMDS-22-64818(PQ); Reviewed: 28-Oct-2022, QC No. JRMDS-22-64818; Revised: 09-Dec-2022, Manuscript No. JRMDS-22-64818(R); Published: 16-Dec-2022

http://sacs17.amberton.edu/